EVE informal group formal submission to GRPE for approval during its 92nd (March 2025) session.
Extensive (90 slide) presentation on the evaluation of ATD results (BioRID II, RID3D, Hybrid III) compared with results from testing conducted on cadavers towards the development of injury criteria under GTR 7.